Rubius Therapeutics Highlights Preclinical Data for RTX-321, a Red Cell Therapeutic™ Oncology Product Candidate for HPV-Positive Cancers, at the American Society of Gene & Cell Therapy 23rd Annual Meeting

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy